Assessing patients’ risk of febrile neutropenia: is there a correlation between physician‐assessed risk and model‐predicted risk?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessing patients’ risk of febrile neutropenia: is there a correlation between physician‐assessed risk and model‐predicted risk?

Published:2015-03-23 Issue:8 Volume:4 Page:1153-1160
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lyman Gary H.¹,Dale David C.²,Legg Jason C.³,Abella Esteban⁴,Morrow Phuong Khanh⁴,Whittaker Sadie⁴,Crawford Jeffrey⁵

Affiliation:

1. Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Research Center Seattle Washington

2. Department of Medicine University of Washington Seattle Washington

3. Global Biostatistical Science Amgen Inc. Thousand Oaks California

4. Hematology/Oncology Amgen Inc. Thousand Oaks California

5. Department of Medicine Duke University School of Medicine and Duke Cancer Institute Durham North Carolina

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.454

Reference27 articles.

1. Risk of mortality in patients with cancer who experience febrile neutropenia

2. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

3. 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

4. Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications

5. Risk Models for Predicting Chemotherapy-Induced Neutropenia

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence and Cancer Clinical Research: III Risk Prediction Models for Febrile Neutropenia in Patients Receiving Cancer Chemotherapy;Cancer Investigation;2024-07-04

2. Rosmarinic acid improves cyclophosphamide-induced immunosuppression in mice by immunomodulatory and antioxidant effects;Food Bioscience;2023-12

3. Perception, Cognition and Thought: Part III: Reasoning, Judgement and Decision-Making;Cancer Investigation;2023-07-27

4. Mitigating acute chemotherapy-associated adverse events in patients with cancer;Nature Reviews Clinical Oncology;2022-10-11

5. Real-world evaluation of supportive care using an electronic health record text-mining tool: G-CSF use in breast cancer patients;Supportive Care in Cancer;2022-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3